Showing results (71-80 of 82) with videos related to
Sort By:
Pageof 9
Cell Reports|April 13, 2022
The hepatocyte insulin receptor is required to program the liver clock and rhythmic gene expressionTiffany Fougeray, Arnaud Polizzi, Marion Régnier, et al.Cell Metabolism|October 24, 2025
Nuclear hormone-sensitive lipase regulates adipose tissue mass and adipocyte metabolismJérémy Dufau, Emeline Recazens, Laura Bottin, et al.EMBO Reports|April 27, 2026
Hepatic FGF21 is not required for fasting metabolism but guides protein appetite post energy depletionJustine Bruse, Clothilde Marbach, Arnaud Polizzi, et al.Science Advances|March 25, 2022
Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptorJean Personnaz, Enzo Piccolo, Alizée Dortignac, et al.Cell Reports|June 8, 2022
ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activityAnne Fougerat, Gabriele Schoiswohl, Arnaud Polizzi, et al.Diabetes|May 6, 2018
Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 DiabetesAmar Abderrahmani, Loïc Yengo, Robert Caiazzo, et al.Annals of the New York Academy of Sciences|March 24, 2023
Immunometabolism at the crossroads of obesity and cancer-a Keystone Symposia reportJennifer Cable, Jeffrey C Rathmell, Erika L Pearce, et al.Plos Biology|April 14, 2025
Liver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kα-dependent hepatocyte signalingMarion Régnier, Arnaud Polizzi, Tiffany Fougeray, et al.Nature Medicine|June 27, 2018
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese womenLesley Hoyles, José-Manuel Fernández-Real, Massimo Federici, et al.Nature Medicine|August 11, 2018
Publisher Correction: Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese womenLesley Hoyles, José-Manuel Fernández-Real, Massimo Federici, et al.Pageof 9